Investment Opportunity In CRO Business In Navi Mumbai
Email
Phone
Google
LinkedIn
Facebook
About Business
The firm operates as a Contract Research Organization (CRO) specializing in generic formulation development, technology transfer, and regulatory support for pharmaceutical products. Its expertise extends to NDDS-based generics as well as new product development.
Partnerships & Capabilities
The company collaborates with EU-GMP, WHO-GMP, TGA, and HCA-certified manufacturing sites to deliver:
- Dossier development
- Analytical method development and validation
- Execution of site variation projects
Additional Services
- Sourcing and supply of pharmaceutical products under customer brands and labels
- Supply of UK unlicensed products
- Out-licensing opportunities across multiple territories
- Regulatory support for MA holders with cost-effective dossier strategies, including BCS Class I drugs eligible for bioequivalence study waivers
Clientele type
The company’s clientele is primarily located in Europe.
Premises
LEASED
Lease per month (in INR): 60.00 K
Security Deposit (in INR): 2.00 L
Carpet Area: 3,500 sq ft
Asking Price Includes
The company is offering a 15% stake and is also open to exploring other deal structures, which will be discussed with potential investors.
Asking Price
INR 1.00 Cr
Minimum ticket size
INR 50.00 L
Reason
The promoters are raising funds to meet the working capital requirements for their large ₹12 crore work order.
Licenses
FDA & CDSCO
Keywords
Business Tags
Fundraising for ₹10 Cr – 500 Cr
Confidential Process Completed in 120 Days
Strategic Preparation, Aligned Investor Outreach and Seamless Closure
Supported by Advisors with 26+ Years of Experience
